sorafenib
A tosylate salt of Sorafenib which is a kinase inhibitor drug. It is used for the treatment of kidney, liver and thyroid cancer. It works by inhibiting the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. Reference standards of Sorafenib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Sorafenib β-D-Glucuronide
[catalogue_number] => PA 19 69540
[category_ids] => ,70,71,75,79,80,82,89,95,
[chemical_name] =>
[weight] => 640.95
[form] => C27H24ClF3N4O9
[cas] => 1130164-93-0
[pslug] => 1130164-93-0-sorafenib-beta-d-glucuronide-pa1969540
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Sorafenib β-D-Glucuronide
Catalogue No.:PA 19 69540
Molecular Formula : C27H24ClF3N4O9
Molecular Weight : 640.95
stdClass Object
(
[pname] => Sorafenib Hemi-Tosylate
[catalogue_number] => PA 19 69550
[category_ids] => ,89,80,79,75,71,82,70,
[chemical_name] =>
[weight] => 464.83
[form] => C21H16ClF3N4O3 .1/2 C7H8O3S
[cas] => 2056030-06-7
[pslug] => 2056030-06-7-sorafenib-hemi-tosylate-pa1969550
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 19 69550
Molecular Formula : C21H16ClF3N4O3 .1/2 C7H8O3S
Molecular Weight : 464.83
